![Michel Ronc](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michel Ronc
Presidente presso Freshmile SAS
Posizioni attive di Michel Ronc
Società | Posizione | Inizio | Fine |
---|---|---|---|
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Direttore/Membro del Consiglio | 01/01/2008 | - |
Freshmile SAS
![]() Freshmile SAS Packaged SoftwareTechnology Services Freshmile SAS offers charging services for electric vehicles. The company was founded by Arnaud Morais headquartered in Entzheim, France. | Presidente | - | - |
Storia della carriera di Michel Ronc
Precedenti posizioni note di Michel Ronc
Società | Posizione | Inizio | Fine |
---|---|---|---|
Demeter Partners SA
![]() Demeter Partners SA Investment ManagersFinance Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors. | Direttore/Membro del Consiglio | 12/07/2005 | 01/03/2013 |
Elf Technologies, Inc.
![]() Elf Technologies, Inc. Investment ManagersFinance Part of TotalEnergies SE, Elf Technologies, Inc. is an American company. | Amministratore Delegato | - | 01/01/1991 |
Presidente | - | 01/01/1991 | |
TOTALENERGIES SE | Corporate Officer/Principal | 01/01/2001 | - |
Total Holdings SAS
![]() Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Direttore Tecnico/Scientifico/R&S | - | - |
Polyplus-transfection SA
![]() Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Direttore/Membro del Consiglio | - | - |
Formazione di Michel Ronc
McGill University | Doctorate Degree |
Ecole Nationale Superieure de Genie Industriel | Undergraduate Degree |
Statistiche
Distribuzione geografica
Francia | 8 |
Canada | 2 |
Sud Africa | 2 |
Posizioni
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Executive Officer | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
TOTALENERGIES SE | Energy Minerals |
Aziende private | 6 |
---|---|
Total Holdings SAS
![]() Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Distribution Services |
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Demeter Partners SA
![]() Demeter Partners SA Investment ManagersFinance Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors. | Finance |
Elf Technologies, Inc.
![]() Elf Technologies, Inc. Investment ManagersFinance Part of TotalEnergies SE, Elf Technologies, Inc. is an American company. | Finance |
Freshmile SAS
![]() Freshmile SAS Packaged SoftwareTechnology Services Freshmile SAS offers charging services for electric vehicles. The company was founded by Arnaud Morais headquartered in Entzheim, France. | Technology Services |
Polyplus-transfection SA
![]() Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
- Borsa valori
- Insiders
- Michel Ronc
- Esperienza